Name | Number of supported studies | Average coverage | |
---|---|---|---|
amacrine cell | 8 studies | 49% ± 16% | |
retinal ganglion cell | 7 studies | 79% ± 25% | |
retinal cone cell | 7 studies | 66% ± 28% | |
retinal rod cell | 7 studies | 57% ± 31% | |
retina horizontal cell | 6 studies | 51% ± 19% | |
retinal bipolar neuron | 5 studies | 50% ± 17% | |
neuron | 5 studies | 34% ± 14% | |
OFF-bipolar cell | 5 studies | 60% ± 27% | |
oligodendrocyte | 5 studies | 26% ± 11% | |
glutamatergic neuron | 4 studies | 37% ± 14% | |
pericyte | 4 studies | 48% ± 14% | |
endothelial cell | 4 studies | 38% ± 9% | |
granule cell | 4 studies | 52% ± 12% | |
interneuron | 4 studies | 40% ± 23% | |
GABAergic amacrine cell | 4 studies | 50% ± 20% | |
glycinergic amacrine cell | 4 studies | 47% ± 18% | |
Mueller cell | 4 studies | 41% ± 22% | |
ON-bipolar cell | 4 studies | 61% ± 23% | |
adipocyte | 3 studies | 18% ± 2% | |
astrocyte | 3 studies | 44% ± 18% | |
rod bipolar cell | 3 studies | 70% ± 18% | |
GABAergic neuron | 3 studies | 35% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1578.50 | 2630 / 2642 | 89% | 6.84 | 630 / 705 |
intestine | 98% | 1029.14 | 949 / 966 | 44% | 1.13 | 233 / 527 |
adrenal gland | 57% | 242.71 | 146 / 258 | 81% | 24.94 | 186 / 230 |
uterus | 98% | 935.00 | 167 / 170 | 24% | 0.94 | 108 / 459 |
ovary | 92% | 370.28 | 165 / 180 | 25% | 0.62 | 108 / 430 |
lung | 70% | 271.12 | 404 / 578 | 46% | 1.33 | 533 / 1155 |
stomach | 63% | 371.72 | 227 / 359 | 49% | 1.37 | 139 / 286 |
pancreas | 38% | 89.73 | 123 / 328 | 74% | 2.21 | 131 / 178 |
breast | 85% | 433.20 | 392 / 459 | 23% | 0.73 | 260 / 1118 |
skin | 63% | 429.29 | 1132 / 1809 | 42% | 1.20 | 196 / 472 |
esophagus | 71% | 695.06 | 1026 / 1445 | 31% | 0.88 | 56 / 183 |
spleen | 100% | 924.87 | 241 / 241 | 0% | 0 | 0 / 0 |
bladder | 76% | 396.43 | 16 / 21 | 23% | 0.62 | 114 / 504 |
eye | 0% | 0 | 0 / 0 | 98% | 4.64 | 78 / 80 |
prostate | 52% | 193.67 | 127 / 245 | 45% | 0.97 | 225 / 502 |
adipose | 95% | 694.88 | 1148 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 2.87 | 26 / 29 |
kidney | 48% | 188.67 | 43 / 89 | 20% | 0.84 | 184 / 901 |
blood vessel | 49% | 191.09 | 658 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 47% | 0.83 | 21 / 45 |
heart | 46% | 148.13 | 398 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 45% | 136.28 | 421 / 929 | 0% | 0 | 0 / 0 |
thymus | 23% | 56.35 | 152 / 653 | 16% | 3.65 | 97 / 605 |
liver | 8% | 21.11 | 19 / 226 | 8% | 0.21 | 31 / 406 |
muscle | 1% | 1.66 | 6 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016071 | Biological process | mRNA metabolic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0070062 | Cellular component | extracellular exosome |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003723 | Molecular function | RNA binding |
GO_1990829 | Molecular function | C-rich single-stranded DNA binding |
GO_0003729 | Molecular function | mRNA binding |
Gene name | PCBP3 |
Protein name | Poly(rC) binding protein 3 Poly(RC) binding protein 3 Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1) |
Synonyms | PCBP3OT PCBP3-OT1 |
Description | FUNCTION: Single-stranded nucleic acid binding protein that binds preferentially to oligo dC. . |
Accessions | Q5MJP6 P57721 J3QT27 ENST00000400308.5 [P57721-2] ENST00000400314.5 [P57721-1] ENST00000681687.1 [P57721-1] ENST00000400309.5 [P57721-4] E9PFP8 ENST00000400304.1 ENST00000449640.5 ENST00000400310.5 [P57721-5] ENST00000400305.5 |